HIVE Blockchain Technologies Ltd. (CVE:HIV – Get Free Report) has received an average rating of “Strong Buy” from the four research firms that are covering the stock, Marketbeat reports. Four research analysts have rated the stock with a strong buy recommendation.
HIV has been the subject of several recent research reports. Rosenblatt Securities upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research report on Friday. Roth Capital upgraded shares of HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Wednesday, December 18th. Finally, Keefe, Bruyette & Woods raised shares of HIVE Blockchain Technologies to a “moderate buy” rating in a report on Wednesday, January 8th.
Read Our Latest Stock Report on HIVE Blockchain Technologies
HIVE Blockchain Technologies Price Performance
HIVE Blockchain Technologies Ltd. is a services company in the Business Services industry.
Recommended Stories
- Five stocks we like better than HIVE Blockchain Technologies
- How to Invest in Tech Stocks and Top Tech Stocks to Consider
- Walgreens Boots Alliance: Don’t Write Off This Asset Champ Yet
- Conference Calls and Individual Investors
- 5 ETFs Poised to Spring Ahead in the Second Quarter
- Insider Buying Explained: What Investors Need to Know
- 3 Stocks With Sky-High Buyback Yields Over the Last 12 Months
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
